Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German Firm Hopes To Drill Into U.S. Market With Anti-Dandruff Ingredient

This article was originally published in The Tan Sheet

Executive Summary

Ichthyol-Gesellschaft is looking to introduce sodium shale oil sulfonate into FDA's OTC monograph so the ingredient can be generally recognized as safe and effective as a treatment for dandruff

You may also be interested in...



Environmental Group Opposes FDA Adding Triclosan To OTC Monographs

Environmental regulations could impede a group's attempt to block all non-medical uses of triclosan - including in OTC products

Environmental Group Opposes FDA Adding Triclosan To OTC Monographs

Environmental regulations could impede a group's attempt to block all non-medical uses of triclosan - including in OTC products

Environmental Group Opposes FDA Adding Triclosan To OTC Monographs

Environmental regulations could impede a group's attempt to block all non-medical uses of triclosan - including in OTC products

Related Content

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel